Increased cardiac output and microvascular blood flow during mild hemoconcentration in hamster window model

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 1, 2006, Pages

  Martini, Judith ^a   Tsai, Amy G ^a,b   Cabrales, Pedro ^b   Johnson, Paul C ^a   Intaglietta, Marcos ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b LA JOLLA BIOENGINEERING INSTITUTE   (United States)

Author keywords

Blood pressure; Blood viscosity; Cardiovascular function; Hematocrit; Shear stress

Indexed keywords

OXYGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; BLOOD TRANSFUSION; BODY WEIGHT; CONTROLLED STUDY; CORONARY ARTERY; CORONARY HEMODYNAMICS; ERYTHROCYTE; HEART; HEART INDEX; HEART OUTPUT; HEMATOCRIT; HEMOCONCENTRATION; MALE; MICROCIRCULATION; MICROVASCULATURE; NONHUMAN; OXIMETRY; OXYGEN TRANSPORT; PRIORITY JOURNAL; VASCULAR RESISTANCE; VENULE;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD VISCOSITY; CARDIAC OUTPUT; CRICETINAE; HEMATOCRIT; HEMOSTASIS; MALE; MESOCRICETUS; MICROCIRCULATION; SHEAR STRENGTH;

EID: 33745698637     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01218.2005     Document Type: Article

References (48)

1. Allaart CP, Sipkema P, and Westerhof N. Effect of perfusion pressure on diastolic stress-strain relations of isolated rat papillary muscle. Am J Physiol Heart Circ Physiol 268: H945-H954, 1995.
2. Altman JD, Kinn J, Duncker DJ, and Bache RJ. Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog. Cardiovasc Res 28: 119-124, 1994.
3. Beall CM, Laskowski D, Strohl KP, Soria R, Villena M, Vargas E, Alarcon AM, Gonzales C, and Erzurum SC. Pulmonary nitric oxide in mountain dwellers. Nature 414: 411-412, 2001.
4. Berdeaux A, Ghaleh B, Dubois-Rande JL, Vigue B, Drieu La Rochelle C, Hittinger L, and Giudicelli JF. Role of vascular endothelium in exercise-induced dilation of large epicardial coronary arteries in conscious dogs. Circulation 89: 2799-2808, 1994.
5. Bernstein RD, Ochoa FY, Xu X, Forfia P, Shen W, Thompson CI, and Hintze TH. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res 79: 840-848, 1996.
6. Bowers LD. Abuse of performance-enhancing drugs in sport. Ther Drug Monit 24: 178-181, 2002.
7. O2 microelectrodes are in agreement. Microcirculation 5: 219-225, 1998.
8. Cabrales P, Acero C, Intaglietta M, and Tsai AG. Measurement of the cardiac output in small animals by thermodilution. Microvasc Res 66: 77-82, 2003.
9. Cabrales P, Intaglietta M, and Tsai AG. Increase plasma viscosity sustains microcirculation after resuscitation from hemorrhagic shock and continuous bleeding. Shock 23: 549-555, 2005.
10. Chu A, Chambers DE, Lin CC, Kuehl WD, and Cobb FR. Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs. Am J Physiol Heart Circ Physiol 258: H1250-H1254, 1990.
11. Chu A, Chambers DE, Lin CC, Kuehl WD, Palmer RM, Moncada S, and Cobb FR. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest 87: 1964-1968, 1991.
12. Colantuoni A, Bertuglia S, and Intaglietta M. Quantitation of rhythmic diameter changes in arterial microcirculation. Am J Physiol Heart Circ Physiol 246: H508-H517, 1984.
13. Crowell JW, Ford RG, and Lewis VM. Oxygen transport in hemorrhagic shock as a function of the hematocrit ratio. Am J Physiol 196: 1033-1038, 1959.
14. Crowell JW and Smith EE. Determinant of the optimal hematocrit. J Appl Physiol 22: 501-504, 1967.
15. Dankelman J, Stassen HG, and Spaan JA. Interaction between Gregg's phenomenon and coronary flow control: a model study. Med Biol Eng Comput 37: 742-749, 1999.
16. De Simone G. Relationship between blood pressure and blood viscosity. Eur Heart J 14: 1724-1725, 1993.
17. Dormandy JA, Hoare E, Colley J, Arrowsmith DE, and Dormandy TL. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J 4: 576-581, 1973.
18. Ekblom BT. Blood boosting and sport. Baillieres Best Pract Res Clin Endocrinol Metab 14: 89-98, 2000.
19. Endrich B, Asaishi K, Götz A, and Messmer K. Technical report: a new chamber technique for microvascular studies in unanesthetized hamsters. Res Exp Med (Berl) 177: 125-134, 1980.
20. Fan FC, Chen RY, Schuessler GB, and Chien S. Effects of hematocrit variations on regional hemodynamics and oxygen transport in the dog. Am J Physiol Heart Circ Physiol 238: H545-H552, 1980.
21. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, and Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28: 53-61, 1996.
22. Gagnon DR, Zhang TJ, Brand FN, and Kannel WB. Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up. Am Heart J 127: 674-682, 1994.
23. Gaudard A, Varlet-Marie E, Bressolle F, and Audran M. Drugs for increasing oxygen and their potential use in doping: a review. Sports Med 33: 187-212, 2003.
24. Gregg DE. Effect of coronary perfusion pressure or coronary flow on oxygen usage of the myocardium. Circ Res 13: 497-500, 1963.
25. Guyton AC, Abernathy B, Langston JB, Kaufmann BN, and Fairchild HM. Relative importance of venous and arterial resistances in controlling venous return and cardiac output. Am J Physiol 196: 1008-1014, 1959.
26. Guyton AC, Coleman TG, and Granger HJ. Circulation: overall regulation. Annu Rev Physiol 34: 13-46, 1972.
27. 26a.Guyton AC. Texbook of Medical Physiology (8th ed.). Philadelphia, PA: Saunders, 1991, p. 106-107.
28. Hart RG and Kanter MC. Hematologic disorders and ischemic stroke. A selective review. Stroke 21: 1111-1121, 1990.
29. Intaglietta M, Silverman NR, and Tompkins WR. Capillary flow velocity measurements in vivo and in situ by television methods. Microvasc Res 10: 165-179, 1975.
30. Intaglietta M and Tompkins WR. On-line microvascular blood cell flow velocity measurement by simplified correlation technique. Microvasc Res 4: 217-220, 1972.
31. O2 measurements by phosphorescence quenching: characteristics and applications of an automated system. Microvasc Res 65: 32-38, 2003.
32. Kuo L and Pittman RN. Influence of hemoconcentration on arteriolar oxygen transport in hamster striated muscle. Am J Physiol Heart Circ Physiol 259: H1694-H1702, 1990.
33. Lamberts RR, Van Rijen MH, Sipkema P, Fransen P, Sys SU, and Westerhof N. Coronary perfusion and muscle lengthening increase cardiac contraction: different stretch-triggered mechanisms. Am J Physiol Heart Circ Physiol 283: H1515-H1522, 2002.
34. Lindenfeld J, Weil JV, Travis VL, and Horwitz LD. Regulation of oxygen delivery during induced polycythemia in exercising dogs. Am J Physiol Heart Circ Physiol 289: H1821-H1825, 2005.
35. Lipowsky HH and Firrell JC. Microvascular hemodynamics during systemic hemodilution and hemoconcentration. Am J Physiol Heart Circ Physiol 250: H908-H922, 1986.
36. Lipowsky HH and Zweifach BW. Application of the "two-slit" photometric technique to the measurement of microvascular volumetric flow rates. Microvasc Res 15: 93-101, 1978.
37. Martini J, Carpentier B, Chavez Negrete A, Frangos JA, and Intaglietta M. Paradoxical hypotension following increased hematocrit and blood viscosity. Am J Physiol Heart Circ Physiol 289: H2136-H2143, 2005.
38. Murray JF, Gold P, and Johnson BL Jr. The circulatory effects of hematocrit variations in normovolemic and hypervolemic dogs. J Clin Invest 42: 1150-1159, 1963.
39. Richardson TQ and Guyton AC. Effects of polycythemia and anemia on cardiac output and other circulatory factors. Am J Physiol 197: 1167-1170, 1959.
40. Ruschitzka FT, Wenger RH, Stallmach T, Quaschning T, de Wit C, Wagner K, Labugger R, Kelm M, Noll G, Rulicke T, Shaw S, Lindberg RL, Rodenwaldt B, Lutz H, Bauer C, Luscher TF, and Gassmann M. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci USA 97: 11609-11613, 2000.
41. Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, and Levey AS. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 40: 27-33, 2002.
42. Smith EE and Crowell JW. Influence of hematocrit ratio on survival of unacclimatized dogs at simulated high altitude. Am J Physiol 205: 1172-1174, 1963.
43. Sorlie PD, Garcia-Palmieri MR, Costas R Jr, and Havlik RJ. Hematocrit and risk of coronary heart disease: the Puerto Rico Health Program. Am Heart J 101: 456-461, 1981.
44. Tohgi H, Yamanouchi H, Murakami M, and Kameyama M. Importance of the hematocrit as a risk factor in cerebral infarction. Stroke 9: 369-374, 1978.
45. O2 measurements by phosphorescence decay method. Am J Physiol Heart Circ Physiol 265: H1434-H1438, 1993.
46. Tsai AG, Friesenecker B, Mazzoni MC, Kerger H, Buerk DG, Johnson PC, and Intaglietta M. Microvascular and tissue oxygen gradients in the rat mesentery. Proc Natl Acad Sci USA 95: 6590-6595, 1998.
47. Tsai AG, Friesenecker B, McCarthy M, Sakai H, and Intaglietta M. Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skin fold model. Am J Physiol Heart Circ Physiol 275: H2170-H2180, 1998.
48. Weisse AB, Calton FM, Kuida H, and Hecht HH. Hemodynamic effects of normovolemic polycythemia in dogs at rest and during exercise. Am J Physiol 207: 1361-1366, 1964.